Market Access Insights
Access the relevant market access data and insights you need on health plans, policy restrictions, PBMs, providers, and more
Report
December 1, 2010
Formulary Advantages in Analgesics for Chronic Pain: How will emerging reformulations and fixed-dose combinations fare among U.S. health plans?
Chronic pain syndromes of neuropathic, nociceptive and mixed origins cause substantial human suffering and disability. Despite the number of pain therapies marketed in the U.S., there remains an unfil…
